The PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumour-suppressor protein is a phosphoinositide 3-phosphatase which antagonizes phosphoinositide 3-kinase-dependent signalling by dephosphorylating PtdIns(3,4,5)P3. Most tumour-derived point mutations of PTEN induce a loss of function, which correlates with profoundly reduced catalytic activity. However, here we characterize a point mutation at the N-terminus of PTEN, K13E from a human glioblastoma, which displayed wild-type activity when assayed in vitro. This mutation occurs within a conserved polybasic motif, a putative PtdIns(4,5)P2-binding site that may participate in membrane targeting of PTEN. We found that catalytic activity against lipid substrates and vesicle binding of wild-type PTEN, but not of PTEN K13E, were greatly stimulated by anionic lipids, especially PtdIns(4,5)P2. The K13E mutation also greatly reduces the efficiency with which anionic lipids inhibit PTEN activity against soluble substrates, supporting the hypothesis that non-catalytic membrane binding orientates the active site to favour lipid substrates. Significantly, in contrast to the wild-type enzyme, PTEN K13E failed either to prevent protein kinase B/Akt phosphorylation, or inhibit cell proliferation when expressed in PTEN-null U87MG cells. The cellular functioning of K13E PTEN was recovered by targeting to the plasma membrane through inclusion of a myristoylation site. Our results establish a requirement for the conserved N-terminal motif of PTEN for correct membrane orientation, cellular activity and tumour-suppressor function.
Skip Nav Destination
Article navigation
Research Article|
April 15 2004
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif
Steven M. WALKER;
Steven M. WALKER
1
Division of Cell Signalling, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Nick R. LESLIE;
Nick R. LESLIE
2
Division of Cell Signalling, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, U.K.
2To whom correspondence should be addressed (e-mail n.r.leslie@dundee.ac.uk).
Search for other works by this author on:
Nevin M. PERERA;
Nevin M. PERERA
Division of Cell Signalling, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Ian H. BATTY;
Ian H. BATTY
Division of Cell Signalling, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, U.K.
Search for other works by this author on:
C. Peter DOWNES
C. Peter DOWNES
Division of Cell Signalling, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
December 01 2003
Revision Received:
January 06 2004
Accepted:
January 07 2004
Accepted Manuscript online:
January 07 2004
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2004
2004
Biochem J (2004) 379 (2): 301–307.
Article history
Received:
December 01 2003
Revision Received:
January 06 2004
Accepted:
January 07 2004
Accepted Manuscript online:
January 07 2004
Citation
Steven M. WALKER, Nick R. LESLIE, Nevin M. PERERA, Ian H. BATTY, C. Peter DOWNES; The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem J 15 April 2004; 379 (2): 301–307. doi: https://doi.org/10.1042/bj20031839
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.